Sept. 2024 Newsletter

The Plant has recently been the site of another pioneering study on the potential benefits of psychedelic compounds for mental health treatment! This research marks a significant milestone in the exploration of new therapeutic avenues for conditions like obsessive-compulsive disorder (OCD).

The focus of this study was to assess the impact of a single dose of psilocybin and a psychedelic mushroom extract on SAPAP3 knockout mice, which are known to exhibit behaviors similar to OCD. The research found that both treatments led to a notable reduction in excessive grooming and anxiety-like behaviors, with the effects lasting up to seven weeks. Interestingly, the mushroom extract showed a stronger effect, suggesting that natural compounds may offer additional benefits over synthetic options.

By leveraging the unique strengths of tenants at The Plant, our business community can integrate sustainability with cutting-edge research; driving scientific innovation that could transform mental health treatments for people around the world. To read the full study's preprint, click here.

To read our full September Newsletter, click here.